Lovelace Medical Center performs first right robotic pleural biopsy


ALBUQUERQUE – April 5, 2024 –Lovelace Medical Center (LMC) completed its first right robotic pleural biopsy. The minimally invasive thoracic procedure was performed by Luis Cerda, M.D., cardiothoracic surgeon with the New Mexico Heart Institute/Lovelace Medical Group, using Intuitive’s Da Vinci Xi robotic system, which makes smaller incisions than the traditional open procedure, resulting in less postoperative pain, reduced infection risk and quicker recovery and hospital stay.

Hip replacement surgeries return hiker’s joy of the outdoors

The driving force behind Jeanne Kuriyan is her active lifestyle and adventurous spirit.

“I have always been extremely active, with daily trips to the gym, coupled with a love of the outdoors,” said Kuriyan, 72, who lives in Corrales, NM with her husband, Jacob.

5 Ways to Decrease Your Risk of Colorectal Cancer

Colorectal cancer is the third most common cancer in both men and women; it is also the second leading cause of cancer-related deaths in the United States. March is Colorectal Cancer Awareness Month, a month set aside to increase awareness and education of colon cancer. According to the American Institute for Cancer Research, almost half (47%) of colorectal cancer could be prevented or significantly delayed with lifestyle and diet modifications. Here are five ways to help you fight colorectal cancer.

SCAD heart attack survivor praises staff at Heart Hospital

Heart disease is the leading cause of death for women, a condition very familiar to Taos, NM resident Kendra Bealor, 57.

Both sides of Bealor’s family have a history of the disease, so the symptoms of a heart attack are very familiar to her. But she was still surprised when the symptoms struck her one Christmas morning.

New Mexico Heart Institute/Lovelace Medical Group enrolls the world’s first patient in the RECOVER IV randomized trial comparing strategies for management of cardiogenic shock


ALBUQUERQUE – January 8, 2024 – New Mexico Heart Institute/Lovelace Medical Group (NMHI) has enrolled the first patient in the world in the RECOVER IV randomized study comparing management strategies for patients with cardiogenic shock using the Impella CP®, an FDA-approved temporary heart pump, versus standard of care.

Determination and attitude spur cyclist’s ride to good health

Joleen Trujillo, 66, has had many opportunities to surrender to debilitating health issues, yet she has persevered and still works hard to overcome her obstacles.

A mother of two sons and grandmother to eight, the Albuquerque resident has battled multiple sclerosis (MS) for the past 28 years.

Lovelace Health System appoints new president and CEO


Troy Greer returns to Lovelace as David Schultz assumes enterprise leadership role

Lovelace Regional Hospital Nationally Recognized with an ‘A’ Leapfrog Hospital Safety Grade


ROSWELL, November 7, 2023 — Lovelace Regional Hospital (LRH) received an “A” safety grade in the Fall 2023 Leapfrog Hospital Safety Grade report, a national distinction recognizing its achievements protecting patients from harm and error in the hospital. This is the sixth safety grade “A” in a row for LRH.

Lovelace Health System appoints veteran healthcare executives to senior leadership roles



ALBUQUERQUE – November 2, 2023 – Lovelace Health System (LHS) today announced the appointments of Brian Miller, BSIE, MSE, as the chief executive officer (CEO) of Lovelace Medical Center (LMC) and administrator of the Heart Hospital of New Mexico (HHNM) and Michael Kueker, MBA, as CEO of Lovelace Medical Group (LMG).

A Love Letter to our Outpatient Rehabilitation staff

Thoughtful ‘thank you’ letters for team members remind us of the important work we do every day and that each interaction matters.

We recently received a letter from Lily Colmenero, whose husband Cesar is battling the effects of Multiple Sclerosis (MS) with bravery, determination and a willingness to work hard against this debilitating disease.

MS is an unpredictable disease of the central nervous system that disrupts the flow of information within the brain and between the brain and body.